Analysis of Voglibose in Pharmaceutical Formulations by HPLC with Post-Column Derivatization
The Application Notebook
Voglibose is an Alpha-Glucosidase inhibitor widely used for the treatment of diabetes. Alpha-glucosidase inhibitors are agents that delay the glucose absorption at the intestinal level and thereby prevent sudden surge of glucose after a meal. Voglibose is the safest and most effective drug of its class.
Maria Ofitserova Ph.D., Sareeta Nerkar, Ph. D., and Michael Pickering Ph.D., Pickering Laboratories
Voglibose is an Alpha-Glucosidase inhibitor widely used for the treatment of diabetes. Alpha-glucosidase inhibitors are agents that delay the glucose absorption at the intestinal level and thereby prevent sudden surge of glucose after a meal. Voglibose is the safest and most effective drug of its class.
Table I: Repeatability studies for different concentration levels
Since Voglibose has no UV chromophore, post-column deriv-atization is employed to produce a fluorescent derivative.
Figure 1
This abstract describes a very sensitive and robust analytical method for the analysis of Voglibose in pharmaceutical tablets. Simple sample preparation and fast analysis time allow for using this method in high throughput environments.
Figure 2
Pickering Laboratories, Inc.
1280 Space Park Way
Mountain View, California 94043
Tel (650) 694-6700
Email: marketing@pickeringlabs.com
Analyze Charge Variants in Antibody-Based Therapeutics Using Cation Exchange Chromatography
July 18th 2024This application note discusses the latest development on high performance cation exchange bio-separation columns for determining charge variants in protein-based biotherapeutics, as well as the strategy on method development.
